Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
The American Journal of Physiology
|
January 1, 1996
Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge
H A Ghofrani, S Rosseau, D Walmrath, et al.
The American Journal of Physiology
|
May 1, 1995
Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in perfused rabbit lungs
L Ermert, H Brückner, D Walmrath, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
Der Anaesthesist
|
February 17, 2017
[Pulmonary embolism]
M Hecker, N Sommer, A Hecker, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
December 2, 2015
[Pulmonary embolism]
M Hecker, N Sommer, A Hecker, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
Critical Care Medicine
|
February 15, 2001
Volume-dependent compliance and ventilation-perfusion mismatch in surfactant-depleted isolated rabbit lungs
G Mols, G Hermle, J Schubert, et al.
The Journal of Laboratory and Clinical Medicine
|
December 26, 2001
Cellular pathophysiology and therapy of pulmonary hypertension
H Olschewski, F Rose, E Grünig, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication
R T Schermuly, N Weissmann, B Enke, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
The American Journal of Physiology
|
January 1, 1996
Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge
H A Ghofrani, S Rosseau, D Walmrath, et al.
The American Journal of Physiology
|
May 1, 1995
Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in perfused rabbit lungs
L Ermert, H Brückner, D Walmrath, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
Der Anaesthesist
|
February 17, 2017
[Pulmonary embolism]
M Hecker, N Sommer, A Hecker, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
December 2, 2015
[Pulmonary embolism]
M Hecker, N Sommer, A Hecker, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
Critical Care Medicine
|
February 15, 2001
Volume-dependent compliance and ventilation-perfusion mismatch in surfactant-depleted isolated rabbit lungs
G Mols, G Hermle, J Schubert, et al.
The Journal of Laboratory and Clinical Medicine
|
December 26, 2001
Cellular pathophysiology and therapy of pulmonary hypertension
H Olschewski, F Rose, E Grünig, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication
R T Schermuly, N Weissmann, B Enke, et al.
Page
of 9